Addition of low-dose methotrexate to infliximab in the treatment of a patient with severe, recalcitrant pustular psoriasis

被引:21
作者
Barland, C [1 ]
Kerdel, FA [1 ]
机构
[1] Univ Miami, Dept Dermatol, Miami, FL 33101 USA
关键词
D O I
10.1001/archderm.139.7.949
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
引用
收藏
页码:949 / 950
页数:2
相关论文
共 6 条
[1]   Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomised trial [J].
Chaudhari, U ;
Romano, P ;
Mulcahy, LD ;
Dooley, LT ;
Baker, DG ;
Gottlieb, AB .
LANCET, 2001, 357 (9271) :1842-1847
[2]   Human anti-chimeric antibody levels correlate with lack of response and infusion reactions following infliximab therapy [J].
Farrell, RJ ;
Alsahli, M ;
Falchuk, KR ;
Peppercorn, MA ;
Michetti, P .
GASTROENTEROLOGY, 2001, 120 (05) :A69-A69
[3]  
Maini RN, 1998, ARTHRITIS RHEUM, V41, P1552, DOI 10.1002/1529-0131(199809)41:9<1552::AID-ART5>3.0.CO
[4]  
2-W
[5]   The effectiveness of tumor necrosis factor α antibody (infliximab) in treating recalcitrant psoriasis -: A report of 2 cases [J].
O'Quinn, RP ;
Miller, JL .
ARCHIVES OF DERMATOLOGY, 2002, 138 (05) :644-648
[6]  
Voigtländer C, 2001, ARCH DERMATOL, V137, P1571